Authors: Stewart, WC Sharpe, ED Stewart, JA Holmes, KT Latham, KE

Citation: Wc. Stewart et al., Additive efficacy of unoprostone isopropyl 0.12% (Rescula) to latanoprost 0.005%, AM J OPHTH, 131(3), 2001, pp. 339-344

Authors: Stewart, WC Sharpe, ED Day, DG Kolker, AE Konstas, AGP Lee, WH Rieser, JC Chopra, H Holmes, KT

Citation: Wc. Stewart et al., Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertension, J OCUL PH T, 16(3), 2000, pp. 251-259

Authors: Stewart, WC Kolker, AE Sharpe, ED Day, DG Holmes, KT Leech, JN Johnson, M Cantrell, JB

Citation: Wc. Stewart et al., Factors associated with long-term progression or stability in primary open-angle glaucoma, AM J OPHTH, 130(3), 2000, pp. 274-279

Authors: Stewart, WC Sharpe, ED Harbin, TS Pastor, SA Day, DG Holmes, KT Stewart, JA

Citation: Wc. Stewart et al., Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure, AM J OPHTH, 129(6), 2000, pp. 723-727

Authors: Stewart, WC Day, DG Sharpe, ED Dubiner, HB Holmes, KT Stewart, JA

Citation: Wc. Stewart et al., Efficacy and safety of timolol solution once daily vs timolol gel added tolatanoprost, AM J OPHTH, 128(6), 1999, pp. 692-696